2018
DOI: 10.1177/2058460117752034
|View full text |Cite
|
Sign up to set email alerts
|

Screening-detected desmoid tumor of the breast: findings at conventional imaging and digital breast tomosynthesis

Abstract: Desmoid tumor of the breast is a rare benign entity that usually is mistaken for carcinoma clinically and radiologically. We report two cases of desmoid tumor of the breast detected by mammography screening using digital breast tomosynthesis (DBT). The larger tumor was detected at both full-field digital mammography (FFDM) and DBT. The smaller desmoid tumor, however, was identified only at tomosynthesis. Mammographic and ultrasonographic findings at diagnostic work-up were consistent with carcinoma of the brea… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

1
0
0

Year Published

2020
2020
2020
2020

Publication Types

Select...
1

Relationship

0
1

Authors

Journals

citations
Cited by 1 publication
(1 citation statement)
references
References 19 publications
1
0
0
Order By: Relevance
“…On imaging, BDF in mammography presented in this study as irregularly limited malignancy-related masses, partly with spicules and without evidence of microcalcifications. Also in agreement with the previous literature descriptions, sonographically, predominantly hypoechoic and irregular lesions were found in the examined group, partly with concomitant dorsal sound cancellation [25-28]. All of the tumors met the imaging criteria for a malignancy-related finding.…”
Section: Discussionsupporting
confidence: 91%
“…On imaging, BDF in mammography presented in this study as irregularly limited malignancy-related masses, partly with spicules and without evidence of microcalcifications. Also in agreement with the previous literature descriptions, sonographically, predominantly hypoechoic and irregular lesions were found in the examined group, partly with concomitant dorsal sound cancellation [25-28]. All of the tumors met the imaging criteria for a malignancy-related finding.…”
Section: Discussionsupporting
confidence: 91%